MRCA Pharmaceutical Benefits Scheme (Cth)
MRCA PHARMACEUTICAL BENEFITS SCHEME
Instrument 2004 No. M22 as amended
made under the
Military Rehabilitation and Compensation Act 2004
This compilation was prepared on 4 April 2012 taking into account amendments up to the
MRCA Pharmaceutical Benefits Scheme (Under Co-payment Data Collection) Determination 2012 (2012 No.M20) (F2012L00743)
Prepared by the Legal Services Group,
Department of Veterans' Affairs, Canberra
CONTENTS
1. Commencement of MRCA Pharmaceutical Benefits Scheme 5
2. Purpose of the MRCA Pharmaceutical Benefits Scheme.......................................... 5
Part 1 — Interpretation
3. Definitions………………………………………………………………………….....5
4. Notification of certain matters in the Explanatory Notes ……………………….....…8
5. Department to notify of certain matters as agent of the Commission.......................... 9
Part 2 — Prescribing of Benefits Procedure by Medical Practitioners...................................... 9
6.. Prior Approval............................................................................................................ 9
7. Restrictions................................................................................................................. 9
8. Prescribing provisions................................................................................................. 10
9. Application of PBS Schedule restrictions and MPBS Schedule restrictions............. 11
10. Prescriptions to conform with State or Territory Law.............................................. 11
11. Form of prescriptions.................................................................................................. 11
12. When prescriptions are invalid................................................................................... 11
13. Maximum quantity and repeats allowed.................................................................... 12
14. Prescribing outside the MPBS Schedule or PBS Schedule........................................ 12
15. Medical Practitioner subject to this Scheme............................................................... 12
Part 3 — Supply of Pharmaceutical Benefits............................................................................ 12
16. Supply of Pharmaceutical Benefits — Procedure by Community Pharmacists......... 12
17. Substitution of lesser priced alternative brand of drug.............................................. 13
18. Community Pharmacist to be satisfied as to entitlement........................................... 13
19. Dispensing of deleted items....................................................................................... 13
20. Use of forms as notified by the Department or the Commission............................... 13
21. Financial responsibility............................................................................................... 13
22. Refund in certain circumstances................................................................................. 14
23. Expenses incurred in obtaining Pharmaceutical Benefits while not in receipt of a pharmaceutical allowance................................................................................................................ 14
Part 4 — Claims by Community Pharmacists............................................................................ 15
24. Lodgement of Claims by Community Pharmacists.................................................... 15
25. Payment subject to compliance.................................................................................. 16
Part 5 — Payments to Community Pharmacists........................................................................ 16
26. Dispensing fee payable to Community Pharmacists................................................... 16
27. Dispensing fee payable to Approved Medical Practitioners and Approved Hospital Authorities 16
28. Other Fees — similar PBS pharmaceutical benefit.................................................... 16
29. Other Fees — notified rates....................................................................................... 16
30. Fees not payable in some circumstances..................................................................... 16
31. Community Pharmacist not entitled to demand or receive payments........................ 17
32. Community Pharmacist to issue receipt where certain payments received................ 17
Part 5A Pharmaceutical Reimbursement
33. Financial responsibility for pharmaceutical reimbursement……………….…......…17
34. Pharmaceutical reimbursement compensation for out-of-pocket expenses....…....…17
35. Amount of pharmaceutical reimbursement.…………………………….….....….….18
36. Eligibility for payment of pharmaceutical reimbursement…………………….....….18
37. Calculation of pharmaceutical allowance component……….……………….….…..18
38. Payment of pharmaceutical reimbursement……….…………………….…….......…19
39. Working out pharmaceutical reimbursement………………………………..…….....19
40. Uncounted co-payment……………………………………………………….…...…20
Part 5B Under Co-payment Data Collection
40A. Giving information....................................................................................................20
Part 6 — Miscellaneous............................................................................................................. 20
41. Standards.................................................................................................................... 20
42. Editions of monographs and standards...................................................................... 20
43. Order of precedence................................................................................................... 20
44. Discretionary powers.................................................................................................. 21
45. Retention of Documents............................................................................................ 21
46. Agreement with the Pharmacy Guild of Australia..................................................... 21
Schedule 1 Transitional and Savings…………………………………………………………..22
Notes to the MRCA Pharmaceutical Benefits Scheme……………………………………......23
Commencement
1. This Determination (known as the MRCA Pharmaceutical Benefits Scheme) commences on 1 January 2005 after the commencement of the Military Rehabilitation and Compensation Treatment (Revocation) Determination Instrument No. M20 of 2004.
2. Purpose of the MRCA Pharmaceutical Benefits Scheme
2. The MRCA Pharmaceutical Benefits Scheme enables Community Pharmacists to supply Pharmaceutical Benefits to Eligible Persons.
Part 1 — Interpretation
3. For the purposes of this Scheme, unless a contrary intention appears:
"Act" means the Military Rehabilitation and Compensation Act 2004;
“accepted disability” means a service injury or a service disease;
Note: service injury and service disease are defined in the Act.
“Approved Hospital Authority” means a hospital authority approved under section 94 of the National Health Act 1953 for the purposes of supplying Pharmaceutical Benefits;
“Approved Medical Practitioner” means a medical practitioner approved under section 92 of the National Health Act 1953 for the purposes of supplying Pharmaceutical Benefits;
“Authority Prescription Form” means the form approved under:
(i) subregulation 13(2) of the National Health (Pharmaceutical Benefits) Regulations; or
(ii) paragraph 14 of declaration No. PB 10 of 1993 made under subsection 85(2) of the National Health Act 1953;
“approved supplier” has the meaning given in Part VII of the National Health Act 1953;
“Commission” means the Military Rehabilitation and Compensation Commission established by section 361 of the Act;
“Community Pharmacist” means:
(a) a registered pharmacist approved for the purposes of section 90 of the National Health Act 1953 in charge of a community pharmacy; or
(b) a registered pharmacist approved for the purposes of section 90 of the National Health Act 1953, being the manager of a registered Friendly Society Dispensary; or
(c) an Approved Hospital Authority; or
(d) an Approved Medical Practitioner;
“concessional beneficiary” has the same meaning it has in section 84 of the National Health Act 1953, in force from time to time;
“concessional beneficiary safety net” has the same meaning it has in section 99F of the National Health Act 1953, in force from time to time;
“co-payment”, in respect of a pharmaceutical benefit, means that part of the price of a pharmaceutical benefit that is borne by the Eligible Person in relation to a Pharmaceutical benefit made available under the Scheme;
“Department” means the Department of Veterans’ Affairs;
“Diagnostic Agents” means Agents intended to facilitate the determination of human disease and/or human physiological states;
“Drugs” or “Medicines” means “goods for therapeutic use” as defined for human use by the Therapeutic Goods Act 1989;
“Eligible Person” means:
(a) a person who holds a Repatriation Health Card - For All Conditions; or
(b) a person who holds a Repatriation Health Card - For Specific Conditions.
“Explanatory Notes” means the text entitled “Explanatory Notes” and the text entitled “RPBS Explanatory Notes” that is published in the document, Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners, having the International Standard Serial Number 1037-3667, and dated 1 February 2002, to the extent that that text is not inconsistent with this Scheme;
“general patient safety net” has the same meaning it has in section 99F of the National Health Act 1953, in force from time to time;
“income support payment” is a service pension (defined in subsection 5Q(1) of the Veterans’ Entitlements Act 1986) or an income support supplement (referred to in Part IIIA of the Veterans’ Entitlements Act 1986).
“income support payment under the Social Security Act 1991” means a payment referred to in the definition of “income support payment” in subsection 23(1) of the Social Security Act 1991.
“Medical Practitioner” has the same meaning as “medical practitioner” has in the Health Insurance Act 1973;
“member” has the meaning it has in the Act and includes a former member.
“member of a couple” has the meaning it has in subsection 5E(2) of the Veterans’ Entitlements Act 1986.
“MRCA supplement” means the compensation payable under section 300 of the Act, in force from time to time;
"MRCA Treatment Principles" means the determination called the MRCA Treatment Principles (Instrument No. M21 of 2004) made by the Commission under section 286 of the Act.
“PBS” means the Pharmaceutical Benefits Scheme authorised under the National Health Act 1953;
“PBS Schedule” means the Schedule of Pharmaceutical Benefits constituted by determinations and declarations under Part VII of the National Health Act 1953 (the Act) — by the Minister who administers that Act — as those determinations and declarations are in force from time to time — and includes any such determination, as in force from time to time, the application of which has been varied under a regulation under the Act.
“pension supplement” has the same meaning it has in subsection 5Q(1) of the Veterans’ Entitlements Act 1986, in force from time to time;
“pharmaceutical allowance” means the component of the MRCA supplement or veterans supplement or pension supplement that is to assist with the purchase of Pharmaceutical benefits, the calculated value of which is referred to in paragraph 5 (pharmaceutical allowance component) of Part 5A;
“Pharmaceutical benefits” has the same meaning as “pharmaceutical benefits” in subsection 91(9) of the Veterans’ Entitlements Act 1986;
“pharmaceutical reimbursement” means the financial amount described in paragraphs 1-3 of Part 5A.
“Repatriation Health Card - For All Conditions” means an identification card, or written authorisation, provided to a person eligible under Part 3 of Chapter 6 of the Act for treatment, subject to the MRCA Treatment Principles, for all injuries or diseases;
“Repatriation Health Card - For Specific Conditions” means an identification card, or written authorisation, provided to a person eligible under Part 3 of Chapter 6 of the Act for treatment, subject to the MRCA Treatment Principles, for a service injury or a service disease;
“RPBS Schedule” means the Schedule of Pharmaceutical Benefits prepared by the Department of Veterans’ Affairs, entitled “Repatriation Schedule of Pharmaceutical Benefits” and dated 1 February 2002;
“safety net ”, in respect of its application to a person under this Scheme, means the concessional beneficiary safety net or general patient safety net, whichever amount first applies to the person for the purposes of section 84C of the National Health Act 1953, in force from time to time;
Note: under section 84C of the National Health Act 1953 a concession card or entitlement card is issued when a person reaches their Safety Net. The card is issued for the “relevant entitlement period”. The relevant entitlement period is the remainder of the calendar year after the card is issued.
“Scheme” means the MRCA Pharmaceutical Benefits Scheme;
“Secretary” has the meaning given in Part 1 of the National Health Act 1953;
“social security pension supplement” means a rate or amount worked out under section 20A of the Social Security Act 1991;
“Standard Prescription Form” means the form approved under paragraph 19(1)(a) of the National Health (Pharmaceutical Benefits) Regulations;
3“veterans supplement” means the payment under section 118A of the Veterans’ Entitlements Act 1986;
Notification of certain matters in the Explanatory Notes
4. Where it is provided for the Department or the Commission to notify of certain matters, the publication of the Explanatory Notes shall be taken to constitute such notification to the extent that the Explanatory Notes are relevant and are not inconsistent with other notification given by the Department or the Commission.
3B. Department to notify of certain matters as agent of the Commission
5. Where it is provided that the Department may notify of certain matters, the Department may only do so for and on behalf of the Commission, as its agent.
Part 2 — Prescribing of Benefits
Procedure by Medical Practitioners4.. Prior Approval
6. (a) The Commission may approve any matters requiring “Prior Approval”; and
(b) Prior Approval must be sought, in advance, in accordance with an Authority Prescription Form.
6. Restrictions
7. Restrictions apply to the prescribing of certain items. These include:
(a) items — quantities and repeats: those listed in the RPBS Schedule or PBS Schedule;
(b) surgical appliances and other treatment aids: surgical appliances and other treatment aids provided under the MRCA Treatment Principles or under the Act may not be prescribed unless specifically listed in the RPBS Schedule;
(c) admixtures: the following restrictions apply to admixtures:
(i) admixture of two or more ready‑prepared items into a single combined form, or the addition of one or more supplementary ingredients to a ready‑prepared item, is not recognised as a Pharmaceutical Benefit;
(ii) the extemporaneous prescribing of two or more official formulary preparations in a single combined form, or the addition of one or more supplementary ingredients to an official formulary preparation, is a recognised Pharmaceutical Benefit; and
(iii) where one or more of the components of a preparation specified in subparagraph (ii) are non‑RPBS Schedule or non-PBS Schedule items, Prior Approval is required for their prescribing;
(d) conformity with standards: no drug or therapeutic substance shall be prescribed unless it conforms with:
(i) the specific or general standards as determined by the relevant Minister under the Therapeutic Goods Act 1989; or
(ii) the British Pharmacopoeia, the United States Pharmacopoeia, the European Pharmacopoeia, the Australian Pharmaceutical Formulary, or a prescribed Pharmacology text of international standing;
(e) basis for prescribing: the prescribing of therapeutic substances other than on the clinical diagnosis of a Medical Practitioner shall be invalid;
(f) approval for therapeutic use: it is invalid to prescribe:
(i) an item that is not approved for therapeutic use in the treatment of human illness by the relevant Commonwealth, State or Territory Government agencies, or
(ii) an item for use if it is not in accordance with the terms and conditions specified by the relevant Government agencies in approving the item as a therapeutic substance;
(g) Prior Approval for non-conforming items: any drug or medicine intended for use other than in conformity with the requirements in subparagraph (d) requires Prior Approval;
(h) PBS Schedule restricted items: the prescribing of PBS Schedule restricted items is to comply with the restrictions relating to the prescribing of such items as indicated in the PBS Schedule unless Prior Approval is obtained to prescribe otherwise;
(j) RPBS Schedule restricted items: the prescribing of RPBS Schedule restricted items under this Part is to comply with the restrictions relating to the prescribing of such items as indicated in the RPBS Schedule unless Prior Approval is obtained to prescribe otherwise;
(k) Prior Approval for non-Schedule items: the prescribing of an item not included in the RPBS Schedule or PBS Schedule requires Prior Approval.
7. Prescribing provisions
8. The PBS Schedule and RPBS Schedule are the primary references for the prescribing of Pharmaceutical Benefits.
8. Application of PBS Schedule restrictions and RPBS Schedule restrictions
9. Restrictions specified in the PBS Schedule and RPBS Schedule which limit supply of items to a particular class of person, or are reserved for specified purposes or require an authority to prescribe, apply unless Prior Approval is obtained to prescribe otherwise.
9. Prescriptions to conform with State or Territory Law
10. For a prescription to be recognised by the Commission it must conform with the provisions of State or Territory law except in so far as that law is inconsistent with this Scheme.
10. Form of prescriptions
11. Prescriptions are to conform with the conditions which the Department or the Commission from time to time notifies, and are to be:
(a) written by Medical Practitioners on an Authority Prescription Form or Standard Prescription Form as the case requires; or
(b) produced on a computer by a Medical Practitioner approved, under paragraph 19(1)(a) of the National Health (Pharmaceutical Benefits) Regulations, to use computer generated prescriptions, by the Secretary to the Department that administers the National Health Act 1953.
11. When prescriptions are invalid
12. A prescription is not a valid Pharmaceutical Benefit if the Medical Practitioner:
(a) prescribes a Pharmaceutical Benefit for a person in respect of whom another prescription for the same benefit has been written on the same day by the same Medical Practitioner; or
(b) prescribes, on the one form, a Pharmaceutical Benefit that is a drug of addiction and another Pharmaceutical Benefit, and directs that the supply of either Pharmaceutical Benefit is to be repeated (but, if no repeats of either item are ordered, the prescription may be accepted provided that this is in accordance with the relevant State or Territory law); or
(c) prescribes a narcotic drug for the Medical Practitioner writing the prescription; or
(d) prescribes on a Standard Prescription Form an item not listed in the RPBS Schedule or PBS Schedule; or
(e) prescribes on a Standard Prescription Form a benefit in contravention of any of the restrictions set out in paragraph 7.
12. Maximum quantity and repeats allowed
13. The quantity and repeats for Scheduled items are to be confined to those specified in the RPBS Schedule or PBS Schedule. However, where inadequate, the Medical Practitioner may seek Prior Approval to prescribe a quantity greater, or a greater number of repeats, than the maximum listed in the RPBS Schedule or PBS Schedule.
13. Prescribing outside the RPBS Schedule or PBS Schedule
14. If a Medical Practitioner is of the clinical opinion that there are no therapeutic alternatives available in the RPBS Schedule or PBS Schedule for the treatment of an Eligible Person, the Medical Practitioner may seek Prior Approval from the Commission to prescribe an item not contained in those Schedules.
14. Medical Practitioner subject to this Scheme
15. Where a Medical Practitioner prescribes for an Eligible Person, the Medical Practitioner shall be subject to the terms and conditions of this Scheme and the Explanatory Notes.
Part 3 — Supply of Pharmaceutical Benefits
15. Supply of Pharmaceutical Benefits — Procedure by Community Pharmacists
16. A Community Pharmacist is required to supply a Pharmaceutical Benefit only upon the surrender of:
(a) a valid Standard Prescription Form; or
(b) a valid Authority Prescription Form; or
(c) a valid repeat authorisation form presented with a duplicate prescription in accordance with the requirements under the PBS;
provided that such documents are in accordance with State or Territory law, or this Scheme and the Explanatory Notes, and with any requirements which the Department or the Commission, from time to time, notifies.
16. Substitution of lesser priced alternative brand of drug
17. Where a valid prescription, issued by a Medical Practitioner, prescribes a brand of drug listed on the PBS or RPBS Schedule, a Community Pharmacist may substitute, with the approval of the prescriber, a lesser priced alternative PBS or RPBS listed brand of the drug in lieu of the brand prescribed and shall endorse the original, duplicate and repeat authorisation accordingly.
17. Community Pharmacist to be satisfied as to entitlement
18.(a) A Community Pharmacist shall not supply a Pharmaceutical Benefit to a person on terms that are appropriate for the supply of a Pharmaceutical Benefit to a holder of a Repatriation Health Card - For All Conditions, a Repatriation Health Card - For Specific Conditions or a Repatriation Pharmaceutical Benefits Card, unless the Community Pharmacist is satisfied that the person is entitled to receive the Pharmaceutical Benefit on those terms.
(b) Without limiting the generality of subparagraph (a), a Community Pharmacist may refuse to supply a Pharmaceutical Benefit to a person on terms that are appropriate for the supply of the Pharmaceutical Benefit to a holder of a Repatriation Health Card - For All Conditions, a Repatriation Health Card - For Specific Conditions or a Repatriation Pharmaceutical Benefits Card, unless the person produces such a card to the Community Pharmacist that indicates that the person is entitled to receive the Pharmaceutical Benefit on those terms.
18. Dispensing of deleted items
19. Prescriptions, including repeat authorisations, for items deleted from the RPBS Schedule or PBS Schedule may not be dispensed as Pharmaceutical Benefits as from the date of effect of deletion, unless the prescriptions for the items comply with Prior Approval arrangements under this Part.
20. Use of forms as notified by the Department or the Commission
20. When supplying a Pharmaceutical Benefit under this Scheme a Community Pharmacist will use and issue such forms, as are notified by the Department or the Commission from time to time, in the manner notified by the Department or the Commission.
23. Financial responsibility
21.
(1) In respect of each Pharmaceutical benefit provided to an Eligible Person under this Scheme, the Commission will accept financial responsibility for:
(a) subject to (b) all of the dispensed price but the co-payment that would be payable by the person if the person were a concessional beneficiary; or
Note 1: (a) deems the person to be a concessional beneficiary for the purposes of working out the co-payment.
Note 2: co-payments not covered by the MRCA supplement may be reimbursed under Part 5A up to the safety net amount for a person.
(b) if the safety net applies to the person, all of the dispensed price.
24. Refund in certain circumstances
22. Where:
(a) a Community Pharmacist charges an Eligible Person an amount in respect of the provision of a Pharmaceutical Benefit; and
(b) information indicating the person’s eligibility under this Scheme was not supplied to the Community Pharmacist; and
(c) the Commission is satisfied that, in the circumstances, the person should be treated as if the relevant information had been supplied,
the person is entitled to be paid by the Commonwealth an amount equal to any amount that the person paid that would not have been payable if the relevant information had been supplied.
25. Expenses incurred in obtaining Pharmaceutical Benefits while not in receipt of a pharmaceutical allowance
23. Where a person would have been eligible to receive a pharmaceutical allowance under section 300 of the Act during a period, but the Department:
(a) did not have the information needed to enable the Commission to make payment of the pharmaceutical allowance; and
(b) has obtained that information since that period; and
the person:
(c) was not in receipt of that allowance during that period; and
(d) has incurred expenses in obtaining Pharmaceutical Benefits during that period which could be obtained under this Scheme; and
(e) has provided material which satisfies the Commission that the person has incurred those expenses,
the Commission may reimburse the person for any or all of those expenses. The maximum amount which may be reimbursed is the amount that the person would have been entitled to receive by way of pharmaceutical allowance during that period had the Department had the information needed to enable the Commission to make payment of the allowance.
Part 4 — Claims by Community Pharmacists
26. Lodgement of Claims by Community Pharmacists
24. Claims by Community Pharmacists under this Part shall be made in accordance with section 99AAA of the National Health Act 1953 as though references in that section, and in the rules made under that section which relate to the supply of and payment for Pharmaceutical Benefits under that Act and its Regulations, were references to the supply of, and payment for, Pharmaceutical Benefits, except that:
(a) prescriptions for the supply of Pharmaceutical Benefits under this Part shall be marked in the S section or S sections (as defined in those rules) with one or more serial numbers allotted in respect of each Pharmaceutical Benefit commencing at “R1” in each claim and continuing consecutively in respect of that claim;
(b) these prescriptions shall be collected into one bundle, separate to the four bundles provided for in those rules, with the prescriptions sorted into the order of the serial numbers allocated under subparagraph (a), with the least serial number at the top of the bundle; and
(c) the information to be provided to the Secretary to the Department that administers the National Health Act 1953, in respect of each supply of a Pharmaceutical Benefit shall include a Form Category (within the meaning of the schedule to those rules) with a value of “8” where the Pharmaceutical Benefit was supplied on an original authority prescription or “9” where the Pharmaceutical Benefit was supplied on a repeat authority prescription, and a Payment Category (within the meaning of that schedule) with a value of “4”.
27. Payment subject to compliance
25. Payment under this Scheme is subject to compliance with paragraph 24.
Part 5 — Payments to Community Pharmacists
28. Dispensing fee payable to Community Pharmacists
26. The dispensing fee payable to Community Pharmacists (excluding Approved Medical Practitioners and Approved Hospital Authorities) for the supply by them, under this Scheme, of Pharmaceutical Benefits in the form of ready prepared items or of extemporaneously prepared items, shall be the fee payable to pharmacists under the PBS for the supply by them of a pharmaceutical benefit of similar form.
29. Dispensing fee payable to Approved Medical Practitioners and Approved Hospital Authorities
27. The dispensing fee payable to Approved Medical Practitioners and Approved Hospital Authorities for the supply by them, under this Scheme, of Pharmaceutical Benefits, in the form of ready prepared items or of extemporaneously prepared items, shall be the fee payable to Approved Medical Practitioners or Approved Hospital Authorities, under the PBS for the supply by them of a pharmaceutical benefit of similar form.
30. Other Fees — similar PBS pharmaceutical benefit
28. Where a Pharmaceutical Benefit is provided which is not covered by paragraphs 26 or 27, payment is to be made in accordance with the fee payable under the PBS for provision of a similar pharmaceutical benefit.
31. Other Fees — notified rates
29. Where a Pharmaceutical Benefit is provided which is not covered by paragraphs 26, 27 or 28, payment is to be made in accordance with such conditions and at such rates as the Department or the Commission from time to time notifies.
32. Fees not payable in some circumstances
30. The fees payable under paragraphs 26, 27, 28 or 29, may not be payable to a Community Pharmacist where that person does not satisfy the requirements of paragraph 18 and supplies Pharmaceutical Benefits to an inEligible Person.
33. Community Pharmacist not entitled to demand or receive payments
31. A Community Pharmacist is not entitled to demand of, or receive from, a person in receipt of a Pharmaceutical Benefit, payment in money or a valuable consideration for goods and services rendered under this Scheme except:
(a) for goods or services that are provided in an emergency; or
(b) for payment of an after-hours fee; or
(c) for payment for packaging material, postage or freight; or
(d) for payment that represents the required payment under the PBS of the price difference between the drug prescribed and supplied and the lowest priced brand of the same drug listed on the PBS Schedule; or
(e) where payment represents the difference between the Commonwealth’s financial responsibility for the provision of the Pharmaceutical Benefit and the dispensed price of the Pharmaceutical Benefit supplied.
34. Community Pharmacist to issue receipt where certain payments received
32. Where a payment is received, under any of subparagraphs 31(a), (b), (c) or (d), from a person in receipt of a Pharmaceutical Benefit, the Community Pharmacist is required to issue that person an official receipt which states:
(a) the goods and/or services provided; and
(b) the date of receipt of those goods and/or services by the person.
Part 5A — Pharmaceutical Reimbursement
33. The Commission may, subject to this Part, accept financial responsibility for the pharmaceutical reimbursement.
Note: if the Commission accepts financial responsibility for a cost in relation to the provision of a Pharmaceutical benefit to an Eligible Person, the Commonwealth pays that cost.
34. The pharmaceutical reimbursement is a financial amount that would compensate an Eligible Person for out-of-pocket expenses the person incurred in respect of a Pharmaceutical benefit provided under this Scheme.
Note: under the Acts Interpretation Act 1901 words in the singular number (e.g. Pharmaceutical benefit) include the plural and words in the plural number include the singular.
35. The amount of pharmaceutical reimbursement is worked out under 39.
Eligibility for Payment of Pharmaceutical Reimbursement
36.
(1) To be eligible for payment of the pharmaceutical reimbursement an Eligible Person must:
(a) have rendered warlike service; and
(b) be entitled to compensation under section 68 or section 75 of the Act.
Note (1): warlike service is defined in subsection 6(1) of the Act.
Note (2): section 68 is about compensation for a service injury or disease that has resulted in an impairment likely to continue indefinitely and section 75 (interim compensation) is about compensation under section 68 or section 71 where an impairment has not stabilised.
Note (3): section 69 of the Act generally requires the degree of impairment to be at least 10 impairment points before compensation is payable under s.68 but in certain cases it can be 5.
Calculation of annual value of pharmaceutical allowance component of MRCA supplement, pension supplement, veterans supplement
37 The annual value of the pharmaceutical allowance is calculated as follows:
(a)for a member in receipt of the MRCA supplement or veterans supplement at different times throughout the year, the amount of $6 per fortnight, indexed (as if the amount is veterans supplement) according to section 198F of the Veterans’ Entitlements Act 1986 since September 2009 (i.e. once annually since 1 January 2010), calculated at a daily rate and valued according to the number of days in the calendar year the MRCA supplement or veterans supplement was payable.
(b)Subject to (c), for a member in receipt of pension supplement, the amount of $6 per fortnight, indexed according to Division 18 of Part IIIB of the Veterans’ Entitlements Act 1986 since September 2009 (i.e. each 20 March and 20 September commencing 20 March 2010), calculated at a daily rate and valued according to the number of days in the calendar year pension supplement was payable;
(c)for a member in receipt of pension supplement who is a member of a couple and whose partner does not receive an income support payment or an income support payment under the Social Security Act 1991 that attracts a social security pension supplement greater than the basic amount of pension supplement — 50% of the amount in (b).
Note: “partner” is defined in section 5 of the Act.
Payment of Pharmaceutical Reimbursement
38.
(1) On and after 1 January 2013 the pharmaceutical reimbursement is payable to a person eligible for it under this Part.
(2) The pharmaceutical reimbursement is payable in the first quarter in each calendar year in respect of co-payments the person made for a Pharmaceutical benefit under this Scheme in the previous calendar year - not being a calendar year before 1 January 2012.
Note 1: calendar year is defined in section 2B of the Acts Interpretation Act 1901.
Pharmaceutical Reimbursement Calculator
39. The pharmaceutical reimbursement for an Eligible Person is worked out as follows:
Step 1 add the co-payments for the Pharmaceutical benefits incurred by the person in the previous calendar year (sum of co-payments) up to the threshold of payments according to the safety net and disregarding any uncounted co-payment.
Step 2 compare the sum of co-payments with the sum of the pharmaceutical allowance component of the MRCA supplement, pension supplement and veterans supplement payable to the person in respect of the previous calendar year.
Step 3 if the sum of co-payments (amount 1) exceeds the sum of the pharmaceutical allowance component of the MRCA supplement, pension supplement and veterans supplement payable (amount 2), the amount by which amount 1 exceeds amount 2 is the pharmaceutical reimbursement for the person.
Note: the amount of any of these supplements may be zero.
40. For the Pharmaceutical Reimbursement Calculator an uncounted co-payment is a co-payment for a Pharmaceutical benefit where the co-payment is not counted for the purposes of the safety net applying to the person.
Note: included here are co-payments for Pharmaceutical benefits dispensed under the “Safety Net 20 Day Rule” (subsection 84C(4AA)) of the National Health Act 1953.
Part 5B — Under Co-payment Data Collection
40A. Giving information
(1) A Community Pharmacist who gives information to the Secretary in relation to the supply, under the Scheme, of a Pharmaceutical benefit by the pharmacist to an Eligible Person, is taken to have given that information under, and for the purposes of, the Scheme, provided that:
(a) no claim for payment is made by the Community Pharmacist on the Commission or Department for dispensing the Pharmaceutical benefit; and
(b) the dispensing price of the pharmaceutical benefit is less than, or equal to, the co-payment that would have been paid by the Eligible Person for the pharmaceutical benefit if it had been dispensed at a price for which a co-payment is payable; and
(c) the information is given in accordance with the requirements, to the extent applicable, that apply under section 98C of the National Health Act 1953 to an approved supplier giving information to the Secretary in relation to the supply to a person of a pharmaceutical benefit, as if references in section 98C to an approved supplier and a pharmaceutical benefit are references to, respectively, a Community Pharmacist and a Pharmaceutical benefit and the pharmaceutical benefit has been supplied under the Scheme.
Note: a Community Pharmacist includes an Approved Hospital Authority.
Part 6 — Miscellaneous
35. Standards
41. The minimum acceptable standard for a Pharmaceutical Benefit is that described in the following documents:
(a) the British Pharmacopoeia or the Pharmaceutical Codex as amended and authorised by regulations under the Therapeutic Goods Act 1989;
(b) the regulations under the Therapeutic Goods Act 1989 which relate to specific standards for drugs;
(c) the Australian Pharmaceutical Formulary which describe drugs and medicinal preparations;
(d) previous editions of the British Pharmacopoeia, Pharmaceutical Codex or the Australian Pharmaceutical Formulary which describe drugs and medicinal preparations; and
(e) the Extra Pharmacopoeia, the European Pharmacopoeia, the United States Pharmacopoeia or similar pharmaceutical texts of international standing which describe drugs.
36. Editions of monographs and standards
42. The monographs and standards contained in the latest authorised editions of the documents listed in paragraph 41 take precedence over earlier editions unless a specific edition is specified.
37. Order of precedence
43. The order of precedence for drug monographs and standards is in the same order as set out in paragraph 41, with the monographs of the British Pharmacopoeia having precedence over all others and thereafter in accordance with State or Territory law.
40. Discretionary powers
44. In order to expedite the processing of claims and to facilitate the efficient management of this Scheme, the Commission may vest in Community Pharmacists acting in good faith such discretionary powers, as it from time to time notifies, to make specified adjustments and/or endorsements to prescriptions and/or repeat authorisations forms. Such discretionary powers may be exercised notwithstanding anything else contained in this Scheme.
41. Retention of Documents
45. A Community Pharmacist is to retain such documents and keep such records as the Department or the Commission from time to time notifies.
3. Agreement with the Pharmacy Guild of Australia
46. The Commission may enter into agreements concerning the administration of this Part with The Pharmacy Guild of Australia and, subject to this Part, shall abide by such agreements.
SCHEDULE 1 TRANSITIONAL AND SAVINGS
(1) MRCA Pharmaceutical Benefits Scheme No. M22 of 2004
(a) any arrangement entered into by the Commission with the Pharmacy Guild of Australia, or any arrangement entered by the Commission or the Department with a person, under Repatriation Pharmaceutical Benefits Scheme as modified and applied by MRCA Instrument No.3 of 2004 entitled "Determination for Providing Treatment" (hereafter called MRCA Instrument No.3 of 2004) being an arrangement that is in force at the commencement of the MRCA Pharmaceutical Benefits Scheme No. M22 of 2004 ¾ is taken to have been entered into under the MRCA Pharmaceutical Benefits Scheme No. M22 of 2004.
(b) any action taken (eg issue of a notice, grant of approval, vesting of powers in Community Pharmacists, giving of a receipt), and any document produced in the course of that action, by the Commission, the Department, a medical practitioner, a Community Pharmacist or an Eligible Person, under MRCA Instrument No.3 of 2004, being action or a document that, at the commencement of the MRCA Pharmaceutical Benefits Scheme No. M22 of 2004, is still in effect, is deemed, respectively, to have been taken or produced under the MRCA Pharmaceutical Benefits Scheme No. M22 of 2004.
Notes to the MRCA Pharmaceutical Benefits Scheme
Note 1
The MRCA Pharmaceutical Benefits Scheme (in force under the Military Rehabilitation and Compensation Act 2004) as shown in this compilation comprises Legislative Instrument 2004 No. M22 (see F2005L00642) amended as indicated in the Tables below.
Table of Legislative Instruments
Year and
numberDate of FRLI
registrationDate of
commencementApplication, saving or
transitional provisions2004 No. M22 17/3/2005 (see
F2005L00642)
1 January 2005 2011 No. M46 13/10/2011 (see
F2011L02067)
1 January 2012 2012 No. M20 30/3/2012 (see
F2012L00743)
1 April 2012
Table of Amendments
ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted Provision affected
How affected
Part 1 Para.3 am. 2011 No. M46; am. 2012 No. M20 Part 3 Para.21 am. 2011 No. M46 PART 5A (paras. 1-8) ad. 2011 No. M46 PART 5A (paras.1-8) renumbered as paras.33-40 2011 No. M46 Part 5B Part 5B (para.40A) ad. 2012 No. M20 Part 6 Para. 41 (formerly 33) am. 2011 No. M46 Para. 42 (formerly 34) am. 2011 No. M46 Para. 43 (formerly 35) am. 2011 No. M46 Para. 44 (formerly 36) am. 2011 No. M46 Para. 45 (formerly 37) am. 2011 No. M46 Para. 46 (formerly 38) am. 2011 No. M46
0
0
0